Scott D. Wilkin

SCOTT D. WILKIN is a Director of Medical Technology Institutional
Research at SG Cowen Securities. His previous experience includes three
years as a Medical Technology Analyst at Warburg Dillon Read, two years
as Manager of Business Development at Dura Pharmaceuticals, and four
years as Market Research Consultant at Boston Biomedical Consultants.
Mr. Wilkin earned his Bachelor’s degree in Biochemistry with a minor in
Economics from Bowdoin College and an MBA from the Harvard Business